Warning letter
LifeCell Corporation [ARCHIVED]: warning letter of May 5, 2011
FDA warning letter 157472 · Center for Devices and Radiological Health
Key facts
| Reference number | 157472 |
|---|---|
| Company | LifeCell Corporation [ARCHIVED] |
| Subject | Sponsor/Monitor/Contract Research Organization |
| Issue date | May 5, 2011 |
| Posted date | May 5, 2011 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 807.81(b), 812.2(b), 812.20(a)(1), 812.40, 812.42, 812, 807.81(a)(3)(ii), 812.3(m)(1), 812.7(a), 812.7(d), 812.2(c) |
| Inspection city | Branchburg |
| Inspection ZIP | 08876 |
| Inspection start date | Nov 2, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: